NAI reports HY 2025 private label contract manufacturing sales of USD 68.87 million, up 9 percent

Reuters
02/14
NAI reports HY 2025 private label contract manufacturing sales of USD 68.87 million, up 9 percent

NAI - Natural Alternatives International Inc. released its earnings for the quarter and half year ended December 31, 2025. The company reported net cash used in operating activities of USD 10.4 million for the half year $(HY)$ ended December 31, 2025. This compares to net cash used in operating activities of USD 3.4 million for the same period in the prior year, with the increase primarily attributed to higher foreign currency exchange losses and increased cash used by changes in accounts receivable, which amounted to USD 3.1 million for the period. The provision for income taxes for the three-month (Q2) period ended December 31, 2025, was an expense of approximately USD 0.2 million, compared to a benefit of approximately USD 0.7 million for the same period in 2024. For the six-month (HY) period ended December 31, 2025, the provision for income taxes was USD 0.3 million, compared to a tax benefit of USD 1.1 million in the prior year. The increase was primarily due to a 5 Swiss withholding tax on a dividend paid by its Swiss subsidiary NAIE to NAI, as well as income before income taxes from NAIE. NAI's primary business remains the provision of private-label contract manufacturing services for companies marketing and distributing vitamins, minerals, herbal, and other nutritional supplements. The company’s revenue continues to rely heavily on sales to a small number of private-label contract manufacturing customers, and results are subject to variations in order timing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NAI - Natural Alternatives International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-004118), on February 13, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10